INSP Share Price Performance
US$0
-87.91 (-100.00%)
Price US$0
Fair ValueUS$52.17
Share Pricen/a
Narrative Update • Aug 04
Inspire Medical Systems, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 24 Fair Values set on narratives written by author
INSP Community Narratives
AN
Fair Value
·Fair Value US$52.17 15.2% overvalued intrinsic discount
Sector Dislocations And Transitory Headwinds Will Create Long-Term Upside Opportunity
0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
AN
Fair Value
·Fair Value US$81.89 26.6% undervalued intrinsic discount
Telemedicine Integration Will Expand Sleep Apnea Solutions For Aging Populations
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value US$39 54.1% overvalued intrinsic discount
Budget Pressures And Rollout Delays Will Constrain Sleep Healthcare Prospects
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Telemedicine Integration Will Expand Sleep Apnea Solutions For Aging Populations
A sleep apnea device maker could get a fresh boost as doctors adopt its newer implant and more patients are guided through care using remote tools. But the story depends heavily on one main product, and growing interest in non-surgical treatments and shifting insurance rules could slow momentum.Read more
AN
US$81.89
26.6% undervalued intrinsic discount
Fair Value
Revenue
3.67% p.a.
Profit Margin
7.22%
Future PE
37.86x
Price in 2029
US$101.37
Budget Pressures And Rollout Delays Will Constrain Sleep Healthcare Prospects
Inspire Medical Systems sells an implanted device for sleep apnea, but growing pressure from insurers and a shift toward at-home alternatives could slow its growth and squeeze profits. The story hinges on whether delayed rollouts and rising costs are temporary bumps—or signs that demand is starting to peak in its core market.Read more
AN
US$39
54.1% overvalued intrinsic discount
Fair Value
Revenue
-0.26% p.a.
Profit Margin
5.15%
Future PE
26.91x
Price in 2029
US$47.24
Sector Dislocations And Transitory Headwinds Will Create Long-Term Upside Opportunity
Inspire Medical Systems hits a rough patch as hospitals take longer than expected to switch over to its new sleep apnea system, but the company says these are short-term bottlenecks rather than fading demand. If insurance coverage improves and the upgrade makes procedures quicker for doctors, growth could pick up again—unless rivals and new non-surgical treatments change the game.Read more
AN
US$52.17
15.2% overvalued intrinsic discount
Fair Value
Revenue
2.56% p.a.
Profit Margin
6.8%
Future PE
25.16x
Price in 2029
US$63.39
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
INSP: Coding And Reimbursement Progress Will Reset Expectations After Guidance Upgrade
Fair Value: US$81.89 26.6% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
INSP: Prolonged Coding Uncertainty Will Pressure Returns Despite Neurostimulation Opportunity
Fair Value: US$39 54.1% overvalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
INSP: CMS Coding Progress Will Gradually Support Future Reimbursement And Earnings Power
Fair Value: US$52.17 15.2% overvalued intrinsic discount
8 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Inspire Medical Systems, Inc. Key Details
About INSP
- Founded
- 2007
- Employees
- 1333
- CEO
- WebsiteView website
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
